Publicacions en què col·labora amb Mª Luz Martínez Chantar (9)

2018

  1. Metabolomic-based noninvasive serum test to diagnose nonalcoholic steatohepatitis: Results from discovery and validation cohorts

    Hepatology Communications, Vol. 2, Núm. 7, pp. 807-820

2017

  1. Deregulated neddylation in liver fibrosis

    Hepatology, Vol. 65, Núm. 2, pp. 694-709

  2. Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis

    Gastroenterology, Vol. 152, Núm. 6, pp. 1449-1461.e7

2013

  1. Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease

    Hepatology, Vol. 57, Núm. 2, pp. 505-514

2012

  1. Obesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression

    Journal of Proteome Research, Vol. 11, Núm. 4, pp. 2521-2532

2010

  1. Liquid chromatography - Mass spectrometry-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of nonalcoholic fatty liver disease

    Journal of Proteome Research, Vol. 9, Núm. 9, pp. 4501-4512

  2. Non-alcoholic fatty liver disease proteomics

    Proteomics - Clinical Applications, Vol. 4, Núm. 4, pp. 362-371

2007

  1. Identification of a gene-pathway associated with non-alcoholic steatohepatitis

    Journal of Hepatology, Vol. 46, Núm. 4, pp. 708-718

2003

  1. Methionine adenosyltransferase II β subunit gene expression provides a proliferative advantage in human hepatoma

    Gastroenterology, Vol. 124, Núm. 4, pp. 940-948